Douglas has announced that it is lowering its sales forecast for the 2024/25 financial year. The German pharmacy chain now ...

TD Cowen lowered the firm’s price target on Waldencast (WALD) to $3.40 from $4.30 and keeps a Hold rating on the shares. The firm updated its ...

Waldencast (NASDAQ:WALD – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at DA Davidson in a ...

Telsey Advisory Group reiterated their outperform rating on shares of Waldencast (NASDAQ:WALD – Free Report) in a research note published on Wednesday morning,Benzinga reports. Telsey Advisory Group ...

Q4 2024 Management View CEO Michel Brousset highlighted that 2024 was a transformative year for Waldencast, with strong performance from its brands, Milk Makeup and Obagi Medical, both significantly ...

Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023FY 2024 Net ...

The S&P 500 Index ($SPX) (SPY) today is down -1.01%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.50%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1. ...

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on KULR Technology Group (KULR – Research Report) ...

LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) ("Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year ...

Waldencast’s 2024 sales estimate is $81.69M, with an expected loss of 1 cent per share. Obagi Medical sales grew 37.4% in Q3, while Milk Makeup sales rose 23.5%. Volatility can create massive tr ...